SUNNYVALE, Calif., June 28 /PRNewswire/ — BARRX  Medical Inc., a world leader in products to treat pre-cancerous tissue in the esophagus, reported today that the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom has published new guidelines approving the use of radiofrequency ablation for the eradication of dysplastic Barrett’s esophagus.

http://www.prnewswire.com/news-releases/the-national-institute-for-health–clinical-excellence-nice-approves-the-use-of-radiofrequency-ablation-for-treatment-of-barretts-esophagus-97296144.html